Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -63.12% is 40% below its 5-year average of -45.03%, near the low end of its 5-year range (-69.85%–11.37%).
As of the fiscal period ended Tuesday, June 30, 2026. 233.36% below its 12-month average of -18.93%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -63.12%.
RETURN ON INVESTED CAPITAL (ROIC)
-63.12%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-18.93%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-34.45%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-45.03%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-233.36%
CURRENT VS 3Y AVG
-83.21%
CURRENT VS 5Y AVG
-40.18%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.64%
median of 838 covered companies
CURRENT VS SECTOR MEDIAN
-77.09%
vs the sector median at left
Stoke Therapeutics, Inc.
Market Cap
$1.57B
Return on Invested Capital (ROIC)
-63.12%
TTM Avg
-18.93%
3Y Avg
-34.45%
5Y Avg
-45.03%
Market Cap
$1.59B
Return on Invested Capital (ROIC)
-47.99%
TTM Avg
-42.50%
3Y Avg
-275.02%
5Y Avg
-275.02%
Market Cap
$1.60B
Return on Invested Capital (ROIC)
-22.55%
TTM Avg
-30.11%
3Y Avg
-30.00%
5Y Avg
-19.97%
Market Cap
$1.54B
Return on Invested Capital (ROIC)
-32.15%
TTM Avg
-60.15%
3Y Avg
-48.54%
5Y Avg
-35.53%
Market Cap
$1.61B
Return on Invested Capital (ROIC)
-50.20%
TTM Avg
-38.39%
3Y Avg
-45.36%
5Y Avg
-41.83%
Market Cap
$1.54B
Return on Invested Capital (ROIC)
8.36%
TTM Avg
8.44%
3Y Avg
9.74%
5Y Avg
16.58%
Market Cap
$1.61B
Return on Invested Capital (ROIC)
-8.93%
TTM Avg
-17.04%
3Y Avg
-10.88%
5Y Avg
-10.88%
Market Cap
$1.61B
Return on Invested Capital (ROIC)
2.43%
TTM Avg
0.22%
3Y Avg
-0.18%
5Y Avg
1.11%
Market Cap
$1.62B
Return on Invested Capital (ROIC)
-7.32%
TTM Avg
-17.29%
3Y Avg
-24.58%
5Y Avg
-25.54%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Stoke Therapeutics, Inc. (STOK) | $1.57B | -63.12% | -18.93% | -34.45% | -45.03% |
| Kestra Medical Technologies, Ltd. (KMTS)vs › | $1.59B | -47.99% | -42.50% | -275.02% | -275.02% |
| uniQure N.V. (QURE)vs › | $1.60B | -22.55% | -30.11% | -30.00% | -19.97% |
| Syndax Pharmaceuticals, Inc. (SNDX)vs › | $1.54B | -32.15% | -60.15% | -48.54% | -35.53% |
| Ocular Therapeutix, Inc. (OCUL)vs › | $1.61B | -50.20% | -38.39% | -45.36% | -41.83% |
| Innoviva, Inc. (INVA)vs › | $1.54B | 8.36% | 8.44% | 9.74% | 16.58% |
| Septerna Inc (SEPN)vs › | $1.61B | -8.93% | -17.04% | -10.88% | -10.88% |
| Omnicell, Inc. (OMCL)vs › | $1.61B | 2.43% | 0.22% | -0.18% | 1.11% |
| Alphatec Holdings, Inc. (ATEC)vs › | $1.62B | -7.32% | -17.29% | -24.58% | -25.54% |
| ANI Pharmaceuticals, Inc. (ANIP)vs › | $1.63B | 9.26% | 2.84% | 1.55% | -0.61% |
ROIC
-63.1%
ROE
-60.2%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -63.12% |
| 2026-03-31 | -45.75% |
| 2025-12-31 | -5.71% |
| 2025-09-30 | 8.54% |
| 2025-06-30 | 11.37% |
| 2025-03-31 | 10.30% |
| 2024-12-31 | -43.79% |
| 2024-09-30 | -48.18% |
| 2024-06-30 | -43.51% |
| 2024-03-31 | -69.85% |
| 2023-12-31 | -58.11% |
| 2023-09-30 | -52.34% |
| 2023-06-30 | -47.76% |
| 2023-03-31 | -41.66% |
| 2022-12-31 | -46.45% |
| 2022-09-30 | -40.87% |
| 2022-06-30 | -35.52% |
| 2022-03-31 | -32.09% |
| 2021-12-31 | -38.82% |
| 2021-09-30 | -31.47% |
| 2021-06-30 | -26.21% |
| 2021-03-31 | -21.31% |
| 2020-12-31 | -18.51% |
| 2020-09-30 | -25.63% |
| 2020-06-30 | -22.34% |
| 2020-03-31 | -19.08% |
| 2019-12-31 | -15.88% |
| 2019-09-30 | -12.46% |
| 2019-06-30 | -9.37% |
| 2019-03-31 | -17.26% |
| 2018-12-31 | -12.16% |
